Research use onlyQualified buyers
Restate Health
RS-RTA-3 vial

GLP-1 & Metabolic

RS-RTA-3 10–60 mg

Research use only

39-residue chain, 4731.2 g/mol, CAS 2381089-83-2. 5 current lot certificates on file; lot RTA10-0803 measured 99.83% by RP-HPLC (214 nm) on 17 August 2026.

Strength

$95.20

per vial · $9.52 per mg

Prices shown are what you pay at checkout, with no account needed. Buyers with a Restate account may see their own pricing when signed in.

Also inAscend Bundle $170.00

1

Measured on lot RTA10-0803

17 August 2026
Identity
RS-RTA-3
Content
10.61 mg
Overall Purity
99.83%
Endotoxin
<0.05 EU/mL
Heavy Metals
<0.01 ppm

Reported by Bioviridian Inc. on certificate COA7580. The vial is labelled 10 mg; the laboratory quantified 10.61 mg. 5 current lots are on file and the figures differ between them — match the lot number on your vial.

Purity trace
Illustrative

A lot’s own chromatogram is printed on its Certificate of Analysis.

Form
Lyophilized powder vial
Documentation
5 current lot certificates on file. View lot documentation
Shipping
Ships from the US in protective packaging with tracking

What RS-RTA-3 is

LY3437943 is a synthetic GIP/GLP-1/glucagon triple receptor agonist (CAS 2381089-83-2, C256H392N64O79, 4731.2 g/mol). It is a 39-residue peptide with Aib residues, alpha-methyl-leucine and a Lys-conjugated (AEEA)-gamma-Glu-C20 diacid side chain, with a C-terminal serinamide. Studied in metabolic research models. Supplied as a lyophilized powder; purity by HPLC with a certificate of analysis for every lot.

RS-RTA-3 in the literature

Three receptors, one 39-residue chain: LY3437943 is a synthetic GIP/GLP-1/glucagon triple receptor agonist (CAS 2381089-83-2, C256H392N64O79, 4731.2 g/mol). Its backbone carries Aib residues and an alpha-methyl-leucine, a lysine bears an (AEEA)-gamma-Glu-C20 diacid side chain, and the chain closes with a C-terminal serinamide. Among the incretin-class peptides in this catalogue it has the widest receptor coverage: NN9535 (RS-SEM-1) addresses the GLP-1 receptor alone, LY3298176 (RS-TRZ-2) adds GIP, and LY3437943 adds glucagon receptor activity on top of both. Metabolic research models are where it is examined. See NN9535, LY3298176 and LY3437943: A Structural Comparison and GLP-1 and Incretin Peptides: What the Class Actually Is.

RS-RTA-3 in the catalogue

Five vial sizes are listed for RS-RTA-3 within GLP-1 & Metabolic: 10 mg at $95.20 ($9.52/mg), 20 mg at $159.60 ($7.98/mg), 30 mg at $215.60 ($7.19/mg), 48 mg at $397.60 ($8.28/mg) and 60 mg at $361.20 ($6.02/mg). The 10 mg vial is the entry size, and the 60 mg vial carries the lowest per-milligram price of the range. The Ascend Bundle at $170.00 contains LY3437943 alongside other catalogue items, and RS-AMR-SEM is the product most often ordered together with it. Sales are research use only, for buyers aged 21 or over; you can request the current lot's certificate from support before paying.

On the certificate

Bioviridian Inc. issued COA7580 for lot RTA10-0803, the 10 mg strength of RS-RTA-3, on 17 August 2026, reporting 99.83% purity. The panel on that certificate covers identity, content, overall purity, endotoxin and heavy metals; nine certificates exist for this product in total and five lots are current. Physically the product is a lyophilised powder. Storage: the powder at −20°C, shielded from light and moisture, with refrigeration at 2–8°C once it is in solution. A printed copy of the certificate is packed in the box, and the same document is kept in the buyer's account.

RS-RTA-3 specification

Purity
≥99% by HPLC · certificates on file
Molecular formula
C256H392N64O79
Molecular weight
4731.2 g/mol
Amino acid count
39
Sequence
39-residue GIP/GLP-1/glucagon triple agonist with Aib residues, α-Me-Leu, and a Lys-conjugated (AEEA)-γGlu-C20 diacid; C-terminal serinamide (per COA)
Synonyms
GGG tri-agonist; LY3437943
Physical form
Lyophilized powder
Solubility
Soluble in bacteriostatic water; consult the product COA for specific solvent recommendations.
Storage
Store lyophilized at -20°C; protect from light and moisture. Reconstitute with bacteriostatic water; refrigerate reconstituted solution at 2-8°C.

Lot documentation for RS-RTA-3

Each lot has its own Certificate of Analysis. Match the lot number printed on your vial to open the certificate for it.

Safety Data Sheet SDS-AP-LY3437943 · v1.0

Open the safety data sheet (PDF)

Reading on RS-RTA-3

Complete the order

Reconstitution solution and bacteriostatic water, ready in the same order.

Questions about RS-RTA-3

Is LY3437943 third-party tested?

Yes. Every lot of LY3437943 (CAS 2381089-83-2) is tested for identity and purity to ≥99% by HPLC, and a lot-matched Certificate of Analysis is available for each batch.

Can I review the Certificate of Analysis before ordering?

Yes. The certificates for current lots of RS-RTA-3 are listed on this page under Lot documentation, each with the identity, content and purity results the laboratory reported. If the lot or strength you need is not listed, ask support what is on file before you order.

Who can order LY3437943 10 mg?

Restate Health supplies qualified researchers, laboratories, and other qualified purchasers only — for research use only. Accounts are verified before ordering is enabled, and this product is not sold to the general public.

How should it be stored and handled?

Supplied as lyophilized powder. Store lyophilized at -20°C; protect from light and moisture. Reconstitute with bacteriostatic water; refrigerate reconstituted solution at 2-8°C. Soluble in bacteriostatic water; consult the product COA for specific solvent recommendations.

How quickly does it ship?

Orders confirmed before 12pm CT typically ship the same business day from our U.S. facility with tracking. Restate Health can confirm current lead time and cold-chain handling for your account.

What did the laboratory measure on the current lot of RS-RTA-3?

Lot RTA10-0803 (10 mg) was tested on 17 August 2026 by Bioviridian Inc. and reported identity RS-RTA-3 (LC-MS/MS), content 10.61 mg (HPLC Quantitation), overall purity 99.83% (RP-HPLC (214 nm)), endotoxin <0.05 EU/mL (<USP85>), heavy metals <0.01 ppm (<USP232>). The certificate is COA7580 and is published in full on this page. 5 current lots are on file and the figures differ between them, so read the certificate for the lot number printed on your vial.

What are the chemical identifiers for RS-RTA-3?

For RS-RTA-3, its CAS number is 2381089-83-2, its molecular formula is C256H392N64O79, its molecular weight is 4731.2 g/mol, it is a 39-residue chain. It is also catalogued as GGG tri-agonist and LY3437943. Identity was confirmed as RS-RTA-3 on lot RTA10-0803 by LC-MS/MS.

Which strengths of RS-RTA-3 are stocked, and what do they cost?

RS-RTA-3 is stocked in 5 strengths: 10 mg at $95.20, 20 mg at $159.60, 30 mg at $215.60, 48 mg at $397.60, 60 mg at $361.20. That is $9.52 per mg at 10 mg and $6.02 per mg at 60 mg. The compound is the same in every vial; the strength is the mass it contains.

Handling RS-RTA-3

One sealed vial per unit ordered, labelled with the compound name, the strength and the lot number, and shipped from the US with tracking. The lot number on the label is what opens its certificate — lot RTA10-0803 is COA7580, and any lot can be checked on the verify page.

For laboratory research use only. Not for human or veterinary use.

Related in GLP-1 & Metabolic

RS-AMR1 vial
GLP-1 & MetabolicIn stock

RS-AMR1

$140.00

Per vial$28.00 per mg

RS-AMR-SEM vial
GLP-1 & MetabolicIn stock

RS-AMR-SEM

5 mg / 5 mg

$201.60

Per vial$20.16 per mg